Abstract

Overproduced yeast ribosomal protein (RP) Rpl26 fails to assemble into ribosomes and is degraded in the nucleus/nucleolus by a ubiquitin-proteasome system quality control pathway comprising the E2 enzymes Ubc4/Ubc5 and the ubiquitin ligase Tom1. tom1 cells show reduced ubiquitination of multiple RPs, exceptional accumulation of detergent-insoluble proteins including multiple RPs, and hypersensitivity to imbalances in production of RPs and rRNA, indicative of a profound perturbation to proteostasis. Tom1 directly ubiquitinates unassembled RPs primarily via residues that are concealed in mature ribosomes. Together, these data point to an important role for Tom1 in normal physiology and prompt us to refer to this pathway as ERISQ, for excess ribosomal protein quality control. A similar pathway, mediated by the Tom1 homolog Huwe1, restricts accumulation of overexpressed hRpl26 in human cells. We propose that ERISQ is a key element of the quality control machinery that sustains protein homeostasis and cellular fitness in eukaryotes.

Article and author information

Author details

  1. Min-Kyung Sung

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0513-6834
  2. Tanya R Porras-Yakushi

    Proteome Exploration Laboratory, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  3. Justin M Reitsma

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  4. Ferdinand M Huber

    Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  5. Michael J Sweredoski

    Proteome Exploration Laboratory, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  6. André Hoelz

    Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  7. Sonja Hess

    Proteome Exploration Laboratory, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
  8. Raymond J Deshaies

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    For correspondence
    deshaies@caltech.edu
    Competing interests
    Raymond J Deshaies, Reviewing Editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3671-9354

Funding

Gordon and Betty Moore Foundation (GBMF775)

  • Tanya R Porras-Yakushi
  • Michael J Sweredoski
  • Sonja Hess

Edward Mallinckrodt (Scholar Award)

  • André Hoelz

Donald E. and Delia B. Baxter Foundation

  • Min-Kyung Sung

National Institutes of Health (1S10RR029594)

  • Sonja Hess

National Institutes of Health (F32GM112308)

  • Justin M Reitsma

Boehringer Ingelheim Fonds

  • Ferdinand M Huber

V Foundation for Cancer Research (Albert Wyrick V Scholar Award)

  • André Hoelz

Sidney Kimmel Foundation for Cancer Research (Scholar Award)

  • André Hoelz

Camille and Henry Dreyfus Foundation (Teacher-Scholar Award)

  • André Hoelz

Howard Hughes Medical Institute

  • Raymond J Deshaies

Beckman Institute, California Institute of Technology

  • Tanya R Porras-Yakushi
  • Michael J Sweredoski
  • Sonja Hess

Heritage Research Institute

  • André Hoelz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Sung et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,984
    views
  • 1,704
    downloads
  • 171
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Min-Kyung Sung
  2. Tanya R Porras-Yakushi
  3. Justin M Reitsma
  4. Ferdinand M Huber
  5. Michael J Sweredoski
  6. André Hoelz
  7. Sonja Hess
  8. Raymond J Deshaies
(2016)
A conserved quality-control pathway that mediates degradation of unassembled ribosomal proteins
eLife 5:e19105.
https://doi.org/10.7554/eLife.19105

Share this article

https://doi.org/10.7554/eLife.19105

Further reading

    1. Biochemistry and Chemical Biology
    Nelson García-Vázquez, Tania J González-Robles ... Michele Pagano
    Research Article

    In healthy cells, cyclin D1 is expressed during the G1 phase of the cell cycle, where it activates CDK4 and CDK6. Its dysregulation is a well-established oncogenic driver in numerous human cancers. The cancer-related function of cyclin D1 has been primarily studied by focusing on the phosphorylation of the retinoblastoma (RB) gene product. Here, using an integrative approach combining bioinformatic analyses and biochemical experiments, we show that GTSE1 (G-Two and S phases expressed protein 1), a protein positively regulating cell cycle progression, is a previously unrecognized substrate of cyclin D1–CDK4/6 in tumor cells overexpressing cyclin D1 during G1 and subsequent phases. The phosphorylation of GTSE1 mediated by cyclin D1–CDK4/6 inhibits GTSE1 degradation, leading to high levels of GTSE1 across all cell cycle phases. Functionally, the phosphorylation of GTSE1 promotes cellular proliferation and is associated with poor prognosis within a pan-cancer cohort. Our findings provide insights into cyclin D1’s role in cell cycle control and oncogenesis beyond RB phosphorylation.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Mai Nguyen, Elda Bauda ... Cecile Morlot
    Research Article

    Teichoic acids (TA) are linear phospho-saccharidic polymers and important constituents of the cell envelope of Gram-positive bacteria, either bound to the peptidoglycan as wall teichoic acids (WTA) or to the membrane as lipoteichoic acids (LTA). The composition of TA varies greatly but the presence of both WTA and LTA is highly conserved, hinting at an underlying fundamental function that is distinct from their specific roles in diverse organisms. We report the observation of a periplasmic space in Streptococcus pneumoniae by cryo-electron microscopy of vitreous sections. The thickness and appearance of this region change upon deletion of genes involved in the attachment of TA, supporting their role in the maintenance of a periplasmic space in Gram-positive bacteria as a possible universal function. Consequences of these mutations were further examined by super-resolved microscopy, following metabolic labeling and fluorophore coupling by click chemistry. This novel labeling method also enabled in-gel analysis of cell fractions. With this approach, we were able to titrate the actual amount of TA per cell and to determine the ratio of WTA to LTA. In addition, we followed the change of TA length during growth phases, and discovered that a mutant devoid of LTA accumulates the membrane-bound polymerized TA precursor.